FDA Okays Tablet Version of Acalabrutinib for All IndicationsThe new formulation can be taken with proton pump inhibitors and other gastric acid reducers. FDA Approvalsadminagosto 6, 2022Uncategorized The new formulation can be taken with proton pump inhibitors and other gastric acid reducers. FDA Approvals